LifeStance Health Group (NASDAQ:LFST) Stock Price Target Raised at KeyCorp

LifeStance Health Group (NASDAQ:LFST) had its price target upped by KeyCorp from $13.00 to $15.00 in a report published on Monday,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other research analysts also recently commented on LFST. Weiss Ratings upgraded shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 11th. JPMorgan Chase & Co. raised their price target on LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday, August 14th. Wall Street Zen lowered LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 5th. Barclays boosted their price objective on LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, September 10th. Finally, Zacks Research lowered LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $13.12.

LifeStance Health Group Stock Up 3.3%

LFST opened at $12.22 on Monday. The firm has a market cap of $4.67 billion, a P/E ratio of 94.01 and a beta of 1.24. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The business has a 50 day moving average price of $12.10 and a 200 day moving average price of $9.62. LifeStance Health Group has a twelve month low of $4.77 and a twelve month high of $13.56.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The company had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. During the same quarter last year, the company posted ($0.01) earnings per share. The company’s revenue for the quarter was up 26.1% compared to the same quarter last year. Research analysts forecast that LifeStance Health Group will post 0.16 EPS for the current year.

Insider Activity at LifeStance Health Group

In related news, COO Lisa Miller sold 47,912 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the transaction, the chief operating officer owned 281,289 shares of the company’s stock, valued at $3,051,985.65. This represents a 14.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CTO Vukasin Paunovich sold 42,067 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $12.87, for a total transaction of $541,402.29. Following the transaction, the chief technology officer owned 205,379 shares of the company’s stock, valued at approximately $2,643,227.73. This represents a 17.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,777,580 shares of company stock valued at $146,433,781 over the last quarter. 3.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On LifeStance Health Group

Several hedge funds and other institutional investors have recently modified their holdings of LFST. WINTON GROUP Ltd boosted its stake in LifeStance Health Group by 522.3% in the 2nd quarter. WINTON GROUP Ltd now owns 186,589 shares of the company’s stock valued at $1,998,000 after buying an additional 156,607 shares in the last quarter. Engineers Gate Manager LP acquired a new position in LifeStance Health Group during the second quarter worth $166,000. Integrated Wealth Concepts LLC acquired a new position in LifeStance Health Group during the second quarter worth $91,000. IFP Advisors Inc lifted its holdings in shares of LifeStance Health Group by 316.5% during the second quarter. IFP Advisors Inc now owns 3,694 shares of the company’s stock valued at $40,000 after acquiring an additional 2,807 shares during the period. Finally, Squarepoint Ops LLC bought a new position in shares of LifeStance Health Group during the second quarter valued at $1,283,000. Institutional investors own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services.